Axonics, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q3 2024.

Location
Irvine, CA
Fiscal year end
31 December
Latest financial report
07 Nov 2024

Shareable Research Card

Axonics, Inc. Financial Facts

Axonics, Inc. has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.

Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.

Context
Latest metrics period: Q3 2024
Latest reported value
Return On Equity -0.89%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.

Open stable link Open latest 10-Q/10-K hub Which companies report the highest revenue?

Return Loop

Why revisit this company facts page

Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.

Latest source-backed update
Latest metrics period Q3 2024
Why come back
Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
  • Current latest metrics period: Q3 2024.
  • Most recent SEC facts end date on this page: 05 Nov 2024.
  • Save this filer to return when the next filing-backed metric period changes the picture.

Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.

Create account to save this filer Open latest 10-Q/10-K hub

Latest update

Latest update for Axonics, Inc.

New fact period available

Latest financial period: Q3 2024. Reopen this facts page to verify the newest reported period against the prior baseline.

Update date

07 Nov 2024

Page type

Company facts

Latest period

Q3 2024

SEC-backed company facts were refreshed from filings filed on 07 Nov 2024.

Open recent updates hub Open latest 10-Q/10-K hub

Benchmark Context

How Return On Equity compares

Return On Equity is down about 57% versus the comparable prior period.

Compared with

Compared with Axonics, Inc.'s recent history first. Same-industry peer context appears only when enough SEC-backed benchmark coverage exists.

Why this is notable

Return On Equity already has a self-history signal here, but same-industry benchmark context waits until the benchmark sample is strong enough.

  • Latest comparable period on this page: Q3 2024.
  • Peer context will appear when enough companies report a comparable value for this metric.
  • Open the metric history first if you want to verify the exact period-to-period change.

Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.

Open Revenues YoY history Which companies report the highest revenue?

How to read key metrics on this page

These short guides explain what the headline metrics mean, what to compare next, and where to open the live SEC-backed example for this company.

Plain-English Guide

How to read Revenue on this page

Revenue is the sales a company reports from customers before most expenses are subtracted.

Why people care

People start here to understand business scale and whether demand is growing before they ask about margins or cash flow.

How to read it

Check the latest reported period first, then compare the same quarter or year against prior periods so seasonality does not distort the story.

Compare next

Compare revenue with gross profit, operating income, and operating cash flow to see whether sales are turning into healthy economics.

Revenue can jump because of acquisitions, pricing changes, or revenue-recognition rules, and reporting periods may differ across companies.

Open a live SEC-backed example

Open Revenue guide

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Create free account to save and revisit this page

Quick Takeaways

  • Axonics, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q3 2024.
  • Headline metric: Return On Equity -0.89%.

What Changed

  • Return On Equity YoY change: -57%.
  • Most recent SEC facts end date: 05 Nov 2024.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Source Evidence

Based on latest 10-Q/10-K

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.

See Original Filing

Latest SEC snapshot (2024-11-05) highlights Return On Equity -0.9%, Return On Assets -0.8%, and Operating Margin -4.8%.

Compare This Company Through SEC-backed Metrics

Use these links to compare Axonics, Inc. against other SEC filers on the same metric, then verify the company history from the paired facts page.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

36.4/100

Weak Confidence medium

Return On Equity

-0.89%

Metric score 0.0/100

Return On Assets

-0.79%

Metric score 0.0/100

Financial Health

Current Ratio
8.16x
Quick Ratio
4.69x
Debt to Equity
0.15x

Strengths

Debt-to-equity and Revenues YoY

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Profitability

Metric Latest value YoY change
Return On Equity -0.89% -57%
Return On Assets -0.79% -57%
Operating Margin -4.8% -47%

Financial Health

Metric Latest value YoY change
Current Ratio 8.16x -39%
Quick Ratio 4.69x -58%
Debt-to-equity 0.15x +27%

Growth

Metric Latest value YoY change
Revenues YoY 26%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 51,109,154 +0.88%
Common Stock, Shares, Outstanding 51,110,021 +0.87%
Common Stock, Value, Issued $5,000 0%
Weighted Average Number of Shares Outstanding, Basic 51,088,073 +3.7%
Weighted Average Number of Shares Outstanding, Diluted 51,088,073 +2%

Supporting Metrics

These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.

Metric Latest value YoY change
Accounts Payable, Current $20,109,000 +37%
Accounts Receivable, after Allowance for Credit Loss, Current $62,644,000 +28%
Accrued Liabilities, Current $5,701,000 -4.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax $6,115,000 +75%
Additional Paid in Capital $1,063,185,000 +4%
Amortization of Intangible Assets $8,983,000 -1%
Assets $774,171,000 +17%
Assets, Current $525,914,000 +11%
Cash and Cash Equivalents, at Carrying Value $239,452,000 +63%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $261,534,000 +78%
Common Stock, Par or Stated Value Per Share 0 0%
Common Stock, Shares Authorized 75,000,000 0%
Common Stock, Shares, Issued 51,110,021 +0.87%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $12,736,000
Deferred Income Tax Liabilities, Net $15,363,000 +12%
Earnings Per Share, Basic 0 +57%
Earnings Per Share, Diluted 0 +52%
Employee-related Liabilities, Current $35,998,000 +177%
General and Administrative Expense $66,287,000 +48%
Goodwill $104,545,000 +9.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,014,000 +79%
Income Tax Expense (Benefit) $2,646,000 -259%
Intangible Assets, Net (Excluding Goodwill) $78,454,000 -2.3%
Inventory, Net $113,861,000 +52%
Liabilities $109,682,000 +119%
Liabilities and Equity $774,171,000 +17%
Liabilities, Current $64,419,000 +81%
Nonoperating Income (Expense) $17,686,000 +6.1%
Operating Income (Loss) $20,700,000 +33%
Operating Lease, Liability, Current $2,611,000 +32%
Operating Lease, Liability, Noncurrent $29,900,000 +3313%
Operating Lease, Payments $2,200,000 +4.8%
Operating Lease, Right-of-Use Asset $20,900,000 +1642%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 0%
Other Assets, Noncurrent $22,478,000 +593%
Preferred Stock, Par or Stated Value Per Share 0 0%
Preferred Stock, Shares Authorized 10,000,000 0%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Outstanding 0
Research and Development Expense $47,053,000 +41%
Retained Earnings (Accumulated Deficit) $392,586,000 -1.5%
Revenue from Contract with Customer, Excluding Assessed Tax $431,902,000 +26%
Selling and Marketing Expense $215,701,000 +21%
Share-based Payment Arrangement, Expense $37,541,000 -11%
Stockholders' Equity Attributable to Parent $664,489,000 +8.8%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .